Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 400 shares at $45.00 ($18K) on 2024-02-27, disclosed to the SEC on 2024-02-29.
Scheduled sale ($18k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-10-14 | $187K | — | Filing → |
| KYMR | SELL | 2025-03-03 | $317K | — | Filing → |